Cigna Group (NYSE:CI) Updates FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 30.450- for the period, compared to the consensus estimate of 30.400. The company issued revenue guidance of -.

Cigna Group Stock Down 1.2%

CI opened at $297.42 on Thursday. The firm’s 50-day simple moving average is $286.64 and its 200-day simple moving average is $281.06. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The firm has a market cap of $78.68 billion, a price-to-earnings ratio of 12.61, a PEG ratio of 1.16 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the company posted $6.74 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Equities research analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 26.45%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CI shares. Guggenheim raised their price objective on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Wolfe Research reissued an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. UBS Group increased their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th. Finally, Raymond James Financial set a $340.00 price objective on Cigna Group in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp lifted its position in Cigna Group by 1.8% during the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after purchasing an additional 224,122 shares during the period. Dodge & Cox grew its position in shares of Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after buying an additional 1,833,389 shares during the period. GQG Partners LLC grew its position in shares of Cigna Group by 14.3% during the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after buying an additional 972,302 shares during the period. Invesco Ltd. raised its stake in shares of Cigna Group by 27.4% during the fourth quarter. Invesco Ltd. now owns 2,421,775 shares of the health services provider’s stock worth $666,545,000 after buying an additional 521,273 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Cigna Group by 1.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,325,173 shares of the health services provider’s stock worth $639,957,000 after buying an additional 23,202 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.